Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01126801 · ClinicalTrials.gov registry record · Phase 2
Effects of Estrogen and Hot Flashes on Mood in Postmenopausal Women
A Phase 2 study, sponsored by Massachusetts General Hospital.
- Terminated
- Registry status
- Phase 2
- Development phase
- 2
- Enrollment target
NCT01126801: Clinical Trial Phase 2 study, sponsored by Massachusetts General Hospital.
NCT01126801 is a Phase 2 study that was terminated before completion, run by Massachusetts General Hospital. The registered enrollment target is 2 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01126801, a Phase 2 study, was terminated before completion, sponsored by Massachusetts General Hospital.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 2 participants
- Enrollment target
Study Summary
This protocol is a controlled study of estradiol therapy in early postmenopausal women with and without frequent hot flashes that will be used to determine whether hot flashes are an important intermediary in the generation of menopause-associated depression.
Interventions
- DRUG Estradiol
- OTHER Placebo control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2010-05 |
| Est. Completion | 2011-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01126801
The ClinicalTrials.gov registry entry for NCT01126801 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Estradiol is the first listed.
NCT01126801 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01126801 about?
NCT01126801 is a clinical study titled "Effects of Estrogen and Hot Flashes on Mood in Postmenopausal Women". This protocol is a controlled study of estradiol therapy in early postmenopausal women with and without frequent hot flashes that will be used to determine whether hot flashes are an important intermediary in the generation of menopause-associated depression.
What is the current status of trial NCT01126801?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 2 participants. The study started on 2010-05. Estimated completion is 2011-02.
What interventions are being tested in trial NCT01126801?
The interventions under investigation include: Estradiol (DRUG), Placebo control (OTHER).
Who is sponsoring clinical trial NCT01126801?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.